TY - JOUR
T1 - Low HbA1c levels and all-cause or cardiovascular mortality among people without diabetes
T2 - The US National Health and Nutrition Examination Survey 1999-2015
AU - Inoue, Kosuke
AU - Nianogo, Roch
AU - Telesca, Donatello
AU - Goto, Atsushi
AU - Khachadourian, Vahe
AU - Tsugawa, Yusuke
AU - Sugiyama, Takehiro
AU - Mayeda, Elizabeth Rose
AU - Ritz, Beate
N1 - Publisher Copyright:
© 2020 The Author(s) 2020; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
PY - 2021/8/1
Y1 - 2021/8/1
N2 - Objective: It is unclear whether relatively low glycated haemoglobin (HbA1c) levels are beneficial or harmful for the long-Term health outcomes among people without diabetes. We aimed to investigate the association between low HbA1c levels and mortality among the US general population. Methods: This study includes a nationally representative sample of 39 453 US adults from the National Health and Nutrition Examination Surveys 1999-2014, linked to mortality data through 2015. We employed the parametric g-formula with pooled logistic regression models and the ensemble machine learning algorithms to estimate the time-varying risk of all-cause and cardiovascular mortality by HbA1c categories (low, 4.0 to <5.0%; mid-level, 5.0 to <5.7%; prediabetes, 5.7 to <6.5%; and diabetes, ≥6.5% or taking antidiabetic medication), adjusting for 72 potential confounders including demographic characteristics, lifestyle, biomarkers, comorbidities and medications. Results: Over a median follow-up of 7.5 years, 5118 (13%) all-cause deaths, and 1116 (3%) cardiovascular deaths were observed. Logistic regression models and machine learning algorithms showed nearly identical predictive performance of death and risk estimates. Compared with mid-level HbA1c, low HbA1c was associated with a 30% (95% CI, 16 to 48) and a 12% (95% CI, 3 to 22) increased risk of all-cause mortality at 5 years and 10 years of follow-up, respectively. We found no evidence that low HbA1c levels were associated with cardiovascular mortality risk. The diabetes group, but not the prediabetes group, also showed an increased risk of all-cause mortality. Conclusions: Using the US national database and adjusting for an extensive set of potential confounders with flexible modelling, we found that adults with low HbA1c were at increased risk of all-cause mortality. Further evaluation and careful monitoring of low HbA1c levels need to be considered.
AB - Objective: It is unclear whether relatively low glycated haemoglobin (HbA1c) levels are beneficial or harmful for the long-Term health outcomes among people without diabetes. We aimed to investigate the association between low HbA1c levels and mortality among the US general population. Methods: This study includes a nationally representative sample of 39 453 US adults from the National Health and Nutrition Examination Surveys 1999-2014, linked to mortality data through 2015. We employed the parametric g-formula with pooled logistic regression models and the ensemble machine learning algorithms to estimate the time-varying risk of all-cause and cardiovascular mortality by HbA1c categories (low, 4.0 to <5.0%; mid-level, 5.0 to <5.7%; prediabetes, 5.7 to <6.5%; and diabetes, ≥6.5% or taking antidiabetic medication), adjusting for 72 potential confounders including demographic characteristics, lifestyle, biomarkers, comorbidities and medications. Results: Over a median follow-up of 7.5 years, 5118 (13%) all-cause deaths, and 1116 (3%) cardiovascular deaths were observed. Logistic regression models and machine learning algorithms showed nearly identical predictive performance of death and risk estimates. Compared with mid-level HbA1c, low HbA1c was associated with a 30% (95% CI, 16 to 48) and a 12% (95% CI, 3 to 22) increased risk of all-cause mortality at 5 years and 10 years of follow-up, respectively. We found no evidence that low HbA1c levels were associated with cardiovascular mortality risk. The diabetes group, but not the prediabetes group, also showed an increased risk of all-cause mortality. Conclusions: Using the US national database and adjusting for an extensive set of potential confounders with flexible modelling, we found that adults with low HbA1c were at increased risk of all-cause mortality. Further evaluation and careful monitoring of low HbA1c levels need to be considered.
KW - Low HbA1c
KW - NHANES
KW - cardiovascular
KW - machine learning
KW - mortality
KW - parametric g-formula
UR - https://www.scopus.com/pages/publications/85116957310
U2 - 10.1093/ije/dyaa263
DO - 10.1093/ije/dyaa263
M3 - Article
C2 - 33378417
AN - SCOPUS:85116957310
SN - 0300-5771
VL - 50
SP - 1373
EP - 1383
JO - International Journal of Epidemiology
JF - International Journal of Epidemiology
IS - 4
ER -